Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Citius Oncology, Inc. (CTOR) had Free Cash Flow per Share of $-0.11 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.67M |
|
$-26.61M |
|
$0.33M |
|
$1.34M |
|
$30.28M |
|
$-28.61M |
|
$1.77M |
|
$-26.84M |
|
$-26.84M |
|
$-26.61M |
|
$-26.61M |
|
$-26.61M |
|
$-26.61M |
|
$-28.61M |
|
$-26.89M |
|
100.03M |
|
100.03M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$29.42M |
|
-- |
|
$71.28M |
|
$100.70M |
|
$58.81M |
|
$3.80M |
|
$6.62M |
|
$65.43M |
|
$35.27M |
|
$35.27M |
|
$35.27M |
|
92.98M |
|
| Cash Flow Statement Financials | |
$-11.19M |
|
$-5.00M |
|
$14.89M |
|
$3.92M |
|
$2.63M |
|
$-1.29M |
|
$7.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.50 |
|
-- |
|
-- |
|
0.10 |
|
0.34 |
|
80.27% |
|
-1716.17% |
|
-1716.17% |
|
-- |
|
-1609.84% |
|
-1595.98% |
|
$-11.19M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.01 |
|
1.55 |
|
58.25 |
|
-75.45% |
|
-75.45% |
|
-26.42% |
|
-68.11% |
|
$0.38 |
|
|
Free Cash Flow per Share |
$-0.11 |
$-0.11 |
|